Medicinal composition comprising SGLT-2 inhibitor and angiotensin receptor blocker
Provided is a pharmaceutical composition comprising an antidiabetic agent and an antihypertensive agent as active ingredients.
1. A pharmaceutical composition comprising comprising an effective amount of a sodium glucose cotransporter-2 (SGLT-2) inhibitor and an effective amount of an angiotensin receptor blocker to control blood pressure,
wherein the SGLT-2 inhibitor is dapagliflozin or a pharmaceutically acceptable salt or solvate thereof, and
wherein the angiotensin receptor blocker is olmesartan, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof.
2. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is a composition for treating a disorder comprising hypertension.
3. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is a composition for treating a disorder comprising hypertension and diabetes.
4. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is for administration to patients with a disorder comprising hypertension or patients with a disorder comprising both hypertension and diabetes.
5. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is a solid formulation.